EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland

John R Kelly iD, Christopher Sheridan, Patricia Iusan, Lisa Coakley, Lisa Burke, Christine Brennan, Annie MacDonald, Jo-Hanna Ivers, Dominic Trepel, Garrath Tormey, Martha Finnegan, Gareth W Young und 1 weitere

International Journal of Neuropsychopharmacology · 2026

DOI: 10.1093/ijnp/pyag028 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Neuropsychopharmacology, 2026. Verfasst von John R Kelly und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Hallucinogens, Mental Disorders, Clinical Trials as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 249 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Classical serotonergic psychedelics, such as psilocybin, show emerging evidence of therapeutic potential across a range of mental health disorders, including depression, anxiety, and substance use disorders, with indications of transdiagnostic efficacy. While early-phase studies yielded encouraging results, recent larger-scale phase 3 trials, such as those evaluating psilocybin for treatment-resistant depression, have shown more modest effects, and further findings from ongoing trials are awaited. Despite the absence of regulatory approvals from the U.S. Food and Drug Administration and European Medicines Agency, a small but growing number of countries have permitted psychedelic therapies within regulated clinical settings. Across these divergent international approaches, the long-term trajectory and real-world impact of these therapies within public health systems remain uncertain. In anticipation of potential future approval, Ireland has an opportunity to draw on international experience and proactively plan for the integration of psychedelic therapies. Building on emerging evidence, international frameworks, and Ireland-specific policy and health system features, this paper examines the challenges of integrating psychedelic therapies into the Irish public healthcare system. These challenges span regulatory approval, Health Technology Assessment, service implementation, workforce capacity, and the evaluation of long-term patient outcomes. The aim is to inform policymakers, practitioners, and researchers about key system-level considerations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensMental DisordersClinical Trials as TopicHumansIrelandPsilocybin

Stichwörter der Autor:innen

clinical trialspsilocybinpsychedelic therapypsychedelic-assisted therapypsychedelics

Substanzen

HallucinogensPsilocybin

Autor:innen und Institutionen

  • Department of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland.
  • Trinity College Institute of Neuroscience, Trinity College Dublin, Ireland.
  • Psychedelic Research Group, Tallaght University Hospital and Trinity College Dublin, Dublin, Ireland.
  • Department of Public Health and Primary Care, Trinity College Dublin, Dublin, Ireland.
  • School of Computer Science and Statistics, Trinity College Dublin, Dublin, Ireland.
  • School of Pharmacy & Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland.

ORCID-Profile: John R Kelly, Andrew Harkin

Förderung

  • Health Research Board

Zitieren

APA

Kelly, J. R., Sheridan, C., Iusan, P., Coakley, L., Burke, L., Brennan, C., MacDonald, A., Ivers, J. H., Trepel, D., Tormey, G., Finnegan, M., Young, G. W., & Harkin, A. (2026). Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyag028

Vancouver

Kelly JR, Sheridan C, Iusan P, Coakley L, Burke L, Brennan C, et al. Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland. International Journal of Neuropsychopharmacology. 2026. doi:10.1093/ijnp/pyag028

BibTeX
@article{Kelly2026,
  author = {Kelly, John R and Sheridan, Christopher and Iusan, Patricia and Coakley, Lisa and Burke, Lisa and Brennan, Christine and MacDonald, Annie and Ivers, Jo-Hanna and Trepel, Dominic and Tormey, Garrath and Finnegan, Martha and Young, Gareth W and Harkin, Andrew},
  title = {Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2026},
  doi = {10.1093/ijnp/pyag028}
}
Kostenlos starten →